Dolby Laboratories (DLB) Tops Q2 EPS by 8c; Offers Strong Q3 EPS Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/20/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
JPMorgan Upgrades Dolby Laboratories (DLB) to Overweight
April 22, 2015 6:45 AM EDTJPMorgan upgraded Dolby Laboratories (NYSE: DLB) from Neutral to Overweight with a price target of $48.00 (from $39.00). Yesterday Dolby Laboratories reported Q2 earnings results.
For an analyst ratings summary and ratings history on Dolby Laboratories... More
